Login

HealthBeacon PLC co-founder and CEO, Jim Joyce, joined Proactive's Stephen Gunnion to discuss the company's developments. 00:10:00

Share On Facebook Share On Twitter

The chief executive of HealthBeacon, Jim Joyce

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Clerkships | Ryan McLeod '07 (Partner, Wachtell, Lipton, Rosen & Katz)
00:10:00
Jean-Claude Maurel on Medesis Pharma’s €7M IPO and Future Plans | Jean-Claude Maurel, CEO, Medesis Pharma SA.
00:10:00
Seeks total return | Christopher Kelliher,Fund Manager,Fidelity Advisor Risk Parity Fund
00:10:00
Demystifying Securitized Fixed Income: Opportunities and Strategies for Investors | John Kerschner, CFA - Head of US Securitised Products | Portfolio Manager of Janus Henderson Investors
00:10:00
Embracing Faith, Family, and Positivity: A Conversation with Bill Abbott, CEO of Great American Media
00:10:00
Cardio Therapeutics aims to revolutionize cardiovascular medicine through groundbreaking research and pivotal clinical trials | David Elsley, CEO, Cardiol Therapeutics Inc.
00:10:00
Daniel Dines of UiPath presents 10 AI innovations poised to change lives at UiPath FORWARD VI 2023.
00:10:00
NMMC Mineral Resource Strategy Overview
00:10:00
Dispelling Myths: What We've Learned About Client Retention in Going Independent
00:10:00
Dynamic business strategies spanning|Arun Kumar,Managing Partner,Celesta (fka WRVI)
00:10:00
"Welcome to the official YouTube channel of Canal C Córdoba, broadcasting the Latin American Telecommunications Congress on July 3, 2019, on Cablevisión channel 7 , featuring their social media platforms."
00:10:00
An incentive based on sustainability: Aker Solutions | KIMBERLEY WOOD, Director, Aker Solutions ASAAKSO:OSL

© 2017 - Neuhu+